Suppr超能文献

趋化因子:效应细胞能否被重新定向到肿瘤部位?

Chemokines: can effector cells be redirected to the site of the tumor?

机构信息

Department of Medicine, University of California Los Angeles Lung Cancer Research Program, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

出版信息

Cancer J. 2010 Jul-Aug;16(4):325-35. doi: 10.1097/PPO.0b013e3181eb33bc.

Abstract

Chemokines (ie, chemoattractant cytokines) are a family of small secreted molecules that mediate leukocyte migration. It is becoming increasingly more evident that chemokines play an integral role in the initiation of a specific immune response. With respect to cancer, chemokines are being studied for both their role in tumor biology and as promising immunotherapy candidates. We review several areas of chemokine importance in tumor immunity and discuss the experimental evidence that is leading to the clinical use of this cytokine family in new treatment approaches for patients with cancer.

摘要

趋化因子(即趋化性细胞因子)是一类小分子分泌蛋白,能介导白细胞迁移。越来越多的证据表明,趋化因子在启动特定免疫反应中起着重要作用。在癌症方面,趋化因子因其在肿瘤生物学中的作用以及作为有前途的免疫治疗候选物而受到研究。我们综述了趋化因子在肿瘤免疫中的几个重要领域,并讨论了导致该细胞因子家族在癌症患者新治疗方法中的临床应用的实验证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验